Diagnosis of gilbert’s syndrome via pyrosequencing in clinical practice-Reference-Cited by-同舟云学术

Diagnosis of gilbert’s syndrome via pyrosequencing in clinical practice

Published:2019-11-30 Issue:6 Volume:9 Page:475-482
ISSN:2411-6564
Container-title:The Russian Archives of Internal Medicine
language:
Short-container-title:Arhivʺ vnutrennej mediciny

Author:

Melnikova L. I.¹,Ilchenko L. Yu.²,Dunaeva E. A.³,Kozitsyna M. V.³,Dribnokhodova O. P.³,Mironov K. O.³

Affiliation:

1. Federal State Budgetary Healthcare Institution Clinical Hospital No. 85, FMBA of Russia

2. Federal State Budgetary Healthcare Institution Clinical Hospital No. 85, FMBA of Russia; Federal State Budgetary Scientific Institution Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products of Russian Academy of Sciences; Federal State Budgetary Educational Institution of H igher Education Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of Russia

3. Federal Budgetary Scientific Institution Central Research Institute of Epidemiology, Rospotrebnadzor

Publisher

Synapse, LLC

Subject

General Medicine

Reference28 articles.

1. Gilbert A.N., Lereboullet P. La cholemie simple familiale. Semaine Medicale. 1901; 21: 241-3.

2. Ilchenko L.Yu., Drozdov V.N., Shulyat'ev I.S. et al. Gilbert's syndrome: clinical and genetic investigation. Ter. arkh. 2006; 2: 48-2. [In Russian].

3. Wagner K.H., Shiels R.G., Llang C.A. et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit. Rev. Clin. Lab. Sci. 2018;55(2):129-39. doi: 10.1080/10408363.2018.1428526.

4. Innocenti F., Ratain M.J. Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park, N.Y.). 2003; 17(5): 52-5.

5. Farago B., Melegh B. Gilbert's syndrome. Orv. Hetil. 2008; 149(27): 1277-2. doi: 10.1556/OH.2008.28381.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Safety of Direct-Acting Antiviral Agentsin Patients with Chronic HCV-Infection and with UGT1A1*28 Polymorphism;Клиническая инфектология и паразитология;2020-10-15

2. The Evaluation of the Efficacy and Safety of Patients with Chronic Hepatitis C and Cirrhosis with Polymorphism UGT1A1*28 Treatment with Direct Antiviral Drugs and Ribavirin;Рецепт;2020-07-21

3. The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism;Clinical Microbiology and Antimicrobial Chemotherapy;2020